Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study

Conditions:   HIV;   Tuberculosis Interventions:   Drug: Clofazimine (CFZ);   Drug: Rifapentine (RPT);   Drug: Isoniazid (INH);   Drug: Pyrazinamide (PZA);   Drug: Ethambutol (EMB);   Drug: Rifampicin (RIF);   Dietary Supplement: Pyridoxine (vitamin B6) Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials